N-methyl-N-[(4-methyl-1,3-thiazol-2-yl)methyl]-1-prop-2-enoyl-3,4-dihydro-2H-quinoline-5-carboxamide
C19H21N3O2S — CID 166420981
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-methyl-N-[(4-methyl-1,3-thiazol-2-yl)methyl]-1-prop-2-enoyl-3,4-dihydro-2H-quinoline-5-carboxamide
N-methyl-N-[(4-methyl-1,3-thiazol-2-yl)methyl]-1-prop-2-enoyl-3,4-dihydro-2H-quinoline-5-carboxamide (PubChem CID 166420981) has the molecular formula C19H21N3O2S and a molecular weight of 355.46 g/mol. Its IUPAC name is N-methyl-N-[(4-methyl-1,3-thiazol-2-yl)methyl]-1-prop-2-enoyl-3,4-dihydro-2H-quinoline-5-carboxamide.
Molecular Properties
| Compound Name | N-methyl-N-[(4-methyl-1,3-thiazol-2-yl)methyl]-1-prop-2-enoyl-3,4-dihydro-2H-quinoline-5-carboxamide |
|---|---|
| PubChem CID | 166420981 |
| Molecular Formula | C19H21N3O2S |
| Molecular Weight | 355.46 g/mol |
| Exact Mass | 355.14 |
| IUPAC Name | N-methyl-N-[(4-methyl-1,3-thiazol-2-yl)methyl]-1-prop-2-enoyl-3,4-dihydro-2H-quinoline-5-carboxamide |
| SMILES | C=CC(=O)N1CCCc2c(C(=O)N(C)Cc3nc(C)cs3)cccc21 |
| InChI | InChI=1S/C19H21N3O2S/c1-4-18(23)22-10-6-8-14-15(7-5-9-16(14)22)19(24)21(3)11-17-20-13(2)12-25-17/h4-5,7,9,12H,1,6,8,10-11H2,2-3H3 |
| InChIKey | SFMOIIWAQSZBFZ-UHFFFAOYSA-N |
| XLogP | 3.19 |
| TPSA | 53.51 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 355.46 |
| LogP ≤ 5 | 3.19 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166420981 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.